Moreover, analysis by the TCGA database revealed that high p62 expression was positively correlated with progression-free survival in ovarian cancer patients (Fig. S6D), suggesting that ovarian cancer patients with high p62 expression have a better prognosis, further suggesting that LOC730101 promotes ovarian cancer drug sensitivity through inhibition of autophagy. Here, SQSTM1 is linked to ovarian carcinoma.